RELAMORELIN
UNII BIW199E18V

Substance Identification & Data

This profile provides standardized clinical and technical data for Relamorelin, uniquely identified by the FDA Unique Ingredient Identifier (UNII) BIW199E18V.

Technical mappings include the Chemical Abstracts Service (CAS) Registry Number 661472-41-9 and the RxNorm Concept ID (RxCUI) N/A. Explore the sections below for detailed nomenclature and a complete directory of NDC-listed products containing this ingredient.

FDA UNII Code

BIW199E18V

CAS Registry Number

661472-41-9

RxNorm Concept ID

N/A

Detailed Substance Profile

Preferred Name

RELAMORELIN

Official standardized name for this substance within the FDA UNII nomenclature system.

InChIKey

C43H50N8O5S

International Chemical Identifier digital signature for unique molecular identification.

SMILES String

KUBPNVYPKPWGRJ-LIVOIKKVSA-N

Line notation for describing the chemical structure and connectivity of atoms.

NCI Thesaurus

C152174

National Cancer Institute reference terminology for clinical and research data.

PubChem CID

44251769

Unique identification number in the NCBI database of chemical substances.

INN ID

9864

Sequential identifier assigned via the WHO International Nonproprietary Name program.

Substance Type

chemical

ISO 11238 classification category (e.g., Chemical, Polymer, Protein).

Ingredient Role

C1(C(N[C@@H](C(N[C@@H](C(N[C@H](C(NC2(CCNCC2)C(N)=O)=O)Cc3ccccc3)=O)Cc4c5c([nH]c4)cccc5)=O)Cc6csc7c6cccc7)=O)CCNCC1

Synonyms and Nomenclature

This section provides a complete list of nomenclature and identifier mappings for Relamorelin. Identifiers are organized into official regulatory terms, commercial trade names, and technical systematic synonyms used to ensure accurate identification across clinical pharmaceutical databases, regulatory filings, and electronic health records.